Oh idk, I don’t listen to the q and a. I’ll at most scan someone’s recounting of it. Either way, they said they are working on that data. I mean look at all the info in the presentation, why accept questions about it when no one had even gotten to see it yet? That ish is complicated so I imagine there would be better formulated questions after digestion. They also want to talk to the FDA about it first, so why front run that conversation?
News 
Market Data 
Discover 
